Recent Finacing
Recent Raise
Greyledge Technologies processes autologous blood- and bone marrow–derived cell therapeutics, operating proprietary QC and analytics systems across 10 cell-processing facilities, integrating product analytics with patient-reported outcomes for customized therapies.